Stay Informed with the Latest Political News on Politics Affairs
As the only signatory of the Antwerp declaration from the home appliances industry and the largest appliance manufacturer in Europe,Beko supports Europe\'s quest for boosting manufacturing strength a
Feb 28, 2025GOTHENBURG,Sweden,Feb. 27,2025-- CEO Dr. Martin Edlund: "Minesto has now demonstrated competitive renewable energy production from an untapped natural resource based on a truly novel and propriet
Feb 28, 2025SHANGHAI,Feb. 27,2025-- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy," the "Company" or "we"),a leading manufacturer of high-purity polysilicon for the global solar
Feb 28, 2025TIANJIN,China,Feb. 27,2025-- The debate on MSCs,mesenchymal stromal cells versus mesenchymal stem cells,continued for more than two decades (since 2006),being the major obstacle for MSCs study and cli
Feb 28, 2025BEIJING,Feb. 27,2025-- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"),the largest and most vibrant social community in China for consumers,professionals and
Feb 28, 2025BARCELONA,Spain,Feb. 27,2025--WIT Software,a global leader in cutting-edge software solutions,is set to make a major impact at Mobile World Congress 2025 (MWC25) in Barcelona with the launch of its l
Feb 28, 2025KASHGAR,China,Feb. 27,2025-- On February 25,the Kashgar region\'s first 220 kV power grid construction project for 2025—the Shuleya Fuquan Photovoltaic Collection Station to Kashgar 220 kV Line Proje
Feb 28, 2025GENEVA,Feb. 27,2025--Heralding the beginning of a new era,Kempinski Hotels have signed a landmark agreement to manage the Nymphenburg Palace Royal Residence. In partnership with HRH Prince Luitpold v
Feb 28, 2025The Annual Report 2024 available for download and printed version available for order The Annual Report 2024 publication consists of Ericsson\'s Financial report 2024,the Corporate Governance report 2
Feb 28, 2025HONG KONG,Feb. 27,2025-- Akeso,Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Australia. AK138D1,a
Feb 28, 2025